Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.

CD3, CD2, and CD28 are functionally distinct receptors on T lymphocytes. Engagement of any of these receptors induces the rapid tyrosine phosphorylation of a shared group of intracellular signaling proteins, including Vav, Cbl, p85 phosphoinositide 3-kinase, and the Src family kinases Lck and Fyn. Ligation of CD3 also induces the tyrosine phosphorylation of HS1, a 75-kDa hematopoietic cell-specific intracellular signaling protein of unknown function. We have examined changes in HS1 phosphorylation after differential stimulation of CD3, CD2, and CD28 to elucidate its role in T cells and to further delineate the signaling pathways recruited by these receptors. Unlike ligation of CD3, stimulation with anti-CD28 mAb or CHO cells expressing the CD28 ligands CD80 or CD86 did not lead to tyrosine phosphorylation of HS1 in Jurkat T cells. Additionally, no tyrosine phosphorylation of HS1 was induced by mitogenic pairs of anti-CD2 mAbs capable of activating the transcription factor NFAT (nuclear factor of activated T cells). Costimulation through CD28 and/or CD2 did not modulate the CD3-dependent phosphorylation of HS1. In vivo studies indicated that CD3-induced HSI phosphorylation was dependent upon both the Src family tyrosine kinase Lck and the tyrosine phosphatase CD45, did not require MEK1 kinase activity, and was regulated by protein kinase C activation. Thus, although CD3, CD28, and CD2 activate many of the same signaling molecules, they differed in their capacity to induce the tyrosine phosphorylation of HSI. Furthermore, activation-dependent tyrosine phosphorylation of HS1 was not required for NFAT transcriptional activation.

[1]  S. Bunnell,et al.  T Cell Receptor–initiated Calcium Release Is Uncoupled from Capacitative Calcium Entry in Itk-deficient T Cells , 1998, The Journal of experimental medicine.

[2]  D. Olive,et al.  CD28 can promote T cell survival through a phosphatidylinositol 3‐kinase‐independent mechanism , 1997, European journal of immunology.

[3]  D. Alexander,et al.  Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70. , 1997, Journal of immunology.

[4]  K. Higashi,et al.  Role of Tyrosine Phosphorylation of HS1 in B Cell Antigen Receptor-mediated Apoptosis , 1997, The Journal of experimental medicine.

[5]  U. Deuschle,et al.  HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. , 1997, Journal of immunology.

[6]  M. Foote.  Ecological Controls on the Evolutionary Recovery of Post-Paleozoic Crinoids , 1996, Science.

[7]  M. Allen,et al.  Human Influence on the Atmospheric Vertical Temperature Structure: Detection and Observations , 1996, Science.

[8]  Y. Takemoto,et al.  Distinct binding patterns of HS1 to the Src SH2 and SH3 domains reflect possible mechanisms of recruitment and activation of downstream molecules. , 1996, International immunology.

[9]  S. Ward.  CD28: a signalling perspective. , 1996, The Biochemical journal.

[10]  A. Marks,et al.  Regulation of the Inositol 1,4,5-Trisphosphate Receptor by Tyrosine Phosphorylation , 1996, Science.

[11]  J. Hutchcroft,et al.  Signaling through CD28/CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase. , 1996, Journal of immunology.

[12]  T. Mak,et al.  Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4 , 1996, Science.

[13]  A. Brunati,et al.  SH2 domains mediate the sequential phosphorylation of HS1 protein by p72syk and Src-related protein tyrosine kinases. , 1996, Biochemistry.

[14]  J. W. Rooney,et al.  Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation , 1995, Molecular and cellular biology.

[15]  T. Yamamoto,et al.  Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. , 1995, Immunity.

[16]  C. Rudd,et al.  p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Hutchcroft,et al.  Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lymphocyte surface receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  I. Taniuchi,et al.  Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  I. Taniuchi,et al.  Antigen‐receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen‐receptor‐coupled tyrosine kinases. , 1995, The EMBO journal.

[20]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[21]  Y. Takemoto,et al.  LckBP1, a proline‐rich protein expressed in haematopoietic lineage cells, directly associates with the SH3 domain of protein tyrosine kinase p56lck. , 1995, The EMBO journal.

[22]  J. Bluestone.  New perspectives of C1328-137-mediated T cell costimulation , 1995 .

[23]  A. Weiss,et al.  Multiple kinases mediate T-cell-receptor signaling. , 1995, Trends in biochemical sciences.

[24]  D. Olive,et al.  The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras , 1994, The Journal of experimental medicine.

[25]  D. Maier,et al.  In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase‐activating protein in Ramos B cells , 1994, European journal of immunology.

[26]  J. Parsons,et al.  The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors. , 1994, Oncogene.

[27]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[28]  A. Nel,et al.  The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. , 1994, The Journal of biological chemistry.

[29]  J. Hutchcroft,et al.  Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. August,et al.  Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. , 1994, Biochemical and biophysical research communications.

[31]  T. Kawakami,et al.  Identification of a protein, SPY75, with repetitive helix-turn-helix motifs and an SH3 domain as a major substrate for protein tyrosine kinase(s) activated by Fc epsilon RI cross-linking. , 1994, Journal of immunology.

[32]  W. Hahn,et al.  T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2. , 1993, Seminars in immunology.

[33]  T. Yamamoto,et al.  Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Schwartz.  Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.

[35]  J. Imboden,et al.  Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells , 1992, Molecular and cellular biology.

[36]  Y. Nishizuka.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[37]  E. Reinherz,et al.  The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation , 1992, The Journal of experimental medicine.

[38]  G. Freeman,et al.  Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells , 1992, The Journal of experimental medicine.

[39]  A. Alcover,et al.  The tyrosine kinase activity of p56lck is increased in human T cells activated via CD2 , 1991, European journal of immunology.

[40]  R. Germain,et al.  CD2 can mediate TCR/CD3-independent T cell activation. , 1991, Journal of immunology.

[41]  A. Weiss,et al.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Schwartz,et al.  A cell culture model for T lymphocyte clonal anergy. , 1990, Science.

[43]  P. Altevogt,et al.  Association of CD2 and CD45 on human T lymphocytes , 1990, Nature.

[44]  P. Altevogt,et al.  Association of CD2 and T200 (CD45) in mouse T lymphocytes. , 1990, International immunology.

[45]  A. Alcover,et al.  The lymphocyte‐specific protein tyrosine kinase p56lck is hyperphosphorylated on serine and tyrosine residues within minutes after activation via T cell receptor or CD2 , 1989, European journal of immunology.

[46]  D. Kitamura,et al.  Isolation and characterization of a novel human gene expressed specifically in the cells of hematopoietic lineage. , 1989, Nucleic acids research.

[47]  G. Crabtree,et al.  Identification of a putative regulator of early T cell activation genes. , 1988, Science.

[48]  S. Meuer,et al.  Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand , 1987, Nature.

[49]  A. Bernard,et al.  A unique epitope on the CD2 molecule defined by the monoclonal antibody 9-1: epitope-specific modulation of the E-rosette receptor and effects on T-cell functions. , 1986, Human immunology.

[50]  R. Parkman,et al.  Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome , 1984, The Journal of experimental medicine.

[51]  G. Longton,et al.  Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. , 1983, Journal of immunology.

[52]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[53]  R. Perlmutter,et al.  Differential signaling by lymphocyte antigen receptors. , 1997, Annual review of immunology.

[54]  D. Cantrell,et al.  T cell antigen receptor signal transduction pathways. , 1996, Annual review of immunology.

[55]  M. Raab.  p56^ and p59^ regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor binding protein GRB-2 and T cell specific kinase ITK: implications for T cell co-stimulation. , 1995 .

[56]  A. Weiss,et al.  The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. , 1994, Annual review of immunology.

[57]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.

[58]  J. Gribben,et al.  Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. , 1994, Current opinion in immunology.

[59]  R. Perlmutter,et al.  Regulation of lymphocyte function by protein phosphorylation. , 1993, Annual review of immunology.

[60]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[61]  P. Linsley,et al.  Role of the CD28 receptor in T-cell activation. , 1990, Immunology today.

[62]  S. Ratnofsky,et al.  The biologic roles of CD2, CD4, and CD8 in T-cell activation. , 1989, Annual review of immunology.